ORI Healthcare Fund: Funding, Team & Investors | Startup Intros

Loading organizations...

ORI Healthcare Fund: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 15, 2022	CG Oncology	$120.0M Series E	Decheng Capital, Brian Liu, Simone Song	Acorn Bioventures, Ally Bridge Group, Malin Corporation, RA Capital Management, Sirona Capital
Oct 8, 2021	AffyImmune Therapeutics	$20.0M Series A	Elaine Yang	—
Dec 10, 2020	CG Oncology	$47.0M Series D	Mutsuo Kanzawa	Camford Capital, Perseverance Capital Management
May 12, 2020	Pillar Biosciences	$29.7M Series C	ORI Healthcare Fund	—
Mar 18, 2019	CG Oncology	$22.0M Series C	Simone Song	Perseverance Capital Management
Nov 30, 2017	Semma Therapeutics	$114.0M Series B	Kevin Raidy, Daniel Auerbach	6 Dimensions Capital, ARCH Venture Partners, F-Prime Capital, JDRF T1D Fund, Medtronic, MPM Capital, Novartis, Sinopharm Capital, Wu Capital
Nov 16, 2017	Arterys	$30.0M Series B	Temasek	DNA Capital, Emergent Medical Partners, Fosun, GE Ventures, NewYork-Presbyterian Hospital, Tom Thornton, Rafael Torres
Mar 2, 2017	TriSalus Life Sciences	$12.8M Series D	Simone Song	—
Nov 24, 2016	Kymab	$100.9M Series C	Simone Song	Bill & Melinda Gates Foundation, CF Woodford Equity Income Fund, Malin Corporation, Shenzhen Hepalink Pharmaceutical, Woodford Patient Capital Trust
Oct 5, 2016	Enable Injections	$30.0M Series A	Simone Song	Bob Coy, Cincinnati Children, Cintrifuse, Ohio Innovation Fund
May 11, 2016	Pillar Biosciences	$18.0M Other Equity	Simone Song	—